Results
The mean age of the patient (22 males and 8 females) and control (21 males and 9 females) groups were 57.3 ± 7.8 and 55.8 ± 9.0 years, respectively (p=0.33). There were no statistically significant differences between the mean IL-1, IL-6, IL-8 and neopterin levels of the patient and control group before initial TURBT (Table 1). In the patient group, there were no statistically significant differences in the preoperative IL-6 and IL-8 levels after both TURBT and intravesical BCG therapy (respectively, X2 (2)=1.333, p=0.513 and X2 (2)=2.778, p=0.249). The mean IL-1 levels of the preoperative, postoperative first control and postoperative second control were 4.09 ± 2.43, 3.99 ± 2.49 and 3.95 ± 2.30,respectively (X2 (2)=10.500, p=0.005). In the pairwise comparisons analysis, there was a significant decrease between the IL-1 levels in the preoperative and postoperative first control (p<0.05) (Figure 2). The mean neopterin levels in the preoperative, postoperative first control and postoperative second control were 3.31 ± 1.18, 2.89 ± 1.60 and 2.89 ± 1.35, respectively (X2 (2)=14.941 p=0.001). In the pairwise comparisons analysis, there were decreases between neopterin levels in the preoperative and postoperative first control (p<0.05), in the preoperative and postoperative second controls (p<0.05) (Figure 3).